Subscribe
Subscribe
Picture of V-Bio Ventures

V-Bio Ventures

We are a life sciences fund investing throughout Europe in start-up and early-stage companies with high growth potential. Our articles cover investment-related topics in life sciences, including innovation trends, the latest business themes and exciting updates on our portfolio companies.
Icon-linkedin Link
Picture of V-Bio Ventures

V-Bio Ventures

We are a life sciences fund investing throughout Europe in start-up and early-stage companies with high growth potential. Our articles cover investment-related topics in life sciences, including innovation trends, the latest business themes and exciting updates on our portfolio companies.
Icon-linkedin Link

Friend or foe: building a healthy relationship with your board

To fund or not to fund: the psychology of investment decisions

V-Bio Ventures invests in new start-up Protealis to uplift sustainable plant protein production

AgomAb’s journey of growth in regenerative medicine

V-Bio Ventures: a fresh fund with a difference

V-Bio Ventures launches its second fund at EUR 78 million

How to build the right team for start-up success

Decades-old discoveries cause paradigm shifts in modern medicine

An insightful solution to eye injections

V-Bio Ventures invests in new start-up Animab in a EUR 3.4 million Seed Financing to improve health and performance of livestock animals

Can Darwin’s theory explain why we get sick?

A novel approach to neurology could bring relief to people in pain

Drug combos: how much is 1 + 1?

Biodol Therapeutics receives EUR 4.5 million to progress its novel pain medication in a Series A led by V-Bio Ventures

V-Bio invests into ExeVir Bio to accelerate development of new treatment conferring broad protection against Covid-19